logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Jian Chen

This inventor holds 53 USPTO granted patents and 12 published patent applications and 10 EPO patents, primarily in Polynucleotide Therapeutics (CPC class 4353). Top assignees: Genentech, Inc., Bristol-Myers Squibb Compnay, Bristol Meyers Squibb Company. Active years: 1998-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jian Chen. Retrieved from https://idiyas.com/inventor/jian-chen-fwt2ath6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 53 

% Patents Active = 77.4

 

Average Co-Inventor Count = 5.3

ph-index = 15

Forward Citations = 656(Granted Patents)

Forward Citations (Not Self Cited) = 642(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Burlingame, CA (US) (1998 - 2001)
  • Plainsboro, NJ (US) (2001)
  • San Mateo, CA (US) (2001 - 2003)
  • Princeton, NJ (US) (2003 - 2013)

Company Filing History:

goldMedal29 out of 3,299 
 
Genentech, Inc.
 patents
silverMedal20 out of 3,742 
 
Bristol-Myers Squibb Compnay
 patents
bronzeMedal2 out of 41 
 
Bristol Meyers Squibb Company
 patents
4. 1 out of 39 
 
Bristol-Myers Squibb
 patents
5. 1 out of 98 
 
Genetech, Inc.
 patents

Years Active: 1998-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
PCSK9 Variants
IL-17 Polypeptides
TRP Channel Family
Therapeutic Uses
Polynucleotides
Antibodies
Pharmaceutical Compositions
Cytokine Polypeptides
Glycine Receptor
Metalloproteases
Splice Variants
Adiponectin Receptor
53 patents (USPTO):Explore Patents
1. 8354264 - Polynucleotides encoding novel PCSK9 variants (2013-01-15),
2. 8338132 - Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof (2012-12-25),
3. 8273703 - IL-17 receptor-like polypeptides and therapeutic uses thereof (2012-09-25),
4. 8105804 - Polynucleotides encoding novel PCSK9 variants (2012-01-31),
5. 8075888 - Methods of treatment using antibodies to IL-17 homologous polypeptides (2011-12-13),
6. 8034342 - Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E (2011-10-11),
7. 7846706 - PCSK9 polypeptides (2010-12-07),
8. 7767418 - Polynucleotide encoding a novel TRP channel family member, LTRPC3, and splice variants thereof (2010-08-03),
9. 7749500 - Antibodies to IL-17 polypeptides and therapeutic uses thereof (2010-07-06),
10. 7718770 - PRO1305-polypeptides (2010-05-18),
11. 7705133 - Antibodies which bind variants of the TRP channel family member, LTRPC3 (2010-04-27),
12. 7696319 - PRO1772 antibodies (2010-04-13),
13. 7598348 - Adiponectin receptor variant, AdipoR2v2 (2009-10-06),
14. 7572618 - Polynucleotides encoding novel PCSK9 variants (2009-08-11),
15. 7563867 - PRO4356 polypeptides (2009-07-21),

Certainly! Here is the article on the inventor Jian Chen:

Title: An Insight into the Innovative Mind of Jian Chen

Introduction:

Jian Chen, a brilliant inventor hailing from Princeton, NJ, has marked his territory in the world of patents with an impressive count of 53. His groundbreaking inventions have significantly impacted the fields of molecular biology and therapeutic treatments.

Latest Patents:

Among his latest patents is the revolutionary creation of polynucleotides encoding novel PCSK9 variants. These polynucleotides offer a gateway to diagnostic and therapeutic methods for combating various diseases and disorders. Additionally, his work on Nucleic acids encoding receptors for IL-17 homologous polypeptides has opened new avenues for treating degenerative cartilaginous disorders and inflammatory diseases.

Career Highlights:

Jian Chen has honed his skills and expertise at prestigious companies like Genentech, Inc. and Bristol-Myers Squibb Company. His tenure at these renowned organizations has not only enriched his knowledge but has also contributed to the development of cutting-edge technologies in the pharmaceutical sector.

Collaborations:

Throughout his career, Jian Chen has collaborated with esteemed professionals such as William I Wood and Paul J Godowski. Their combined efforts have led to the creation of innovative solutions that have the potential to revolutionize the healthcare industry.

Conclusion:

In conclusion, Jian Chen stands as a beacon of innovation and excellence in the realm of molecular biology and therapeutic advancements. His relentless dedication to pushing the boundaries of scientific discovery continues to inspire aspiring inventors and researchers worldwide, leaving a lasting impact on the landscape of modern medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…